1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Aesthetic Devices - Medical Devices Pipeline Assessment, 2015

Aesthetic Devices - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, “Aesthetic Devices - Medical Devices Pipeline Assessment, 2015" provides an overview of Aesthetic Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Aesthetic Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Aesthetic Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Aesthetic Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Aesthetic Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Aesthetic Devices - Medical Devices Pipeline Assessment, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 15
2 Introduction 16
2.1 Aesthetic Devices Overview 16
3 Products under Development 17
3.1 Aesthetic Devices - Pipeline Products by Stage of Development 17
3.2 Aesthetic Devices - Pipeline Products by Segment 18
3.3 Aesthetic Devices - Pipeline Products by Territory 19
3.4 Aesthetic Devices - Pipeline Products by Regulatory Path 21
3.5 Aesthetic Devices - Pipeline Products by Estimated Approval Date 22
3.6 Aesthetic Devices - Ongoing Clinical Trials 23
4 Aesthetic Devices - Pipeline Products under Development by Companies 24
4.1 Aesthetic Devices Companies - Pipeline Products by Stage of Development 24
4.2 Aesthetic Devices - Pipeline Products by Stage of Development 27
5 Aesthetic Devices Companies and Product Overview 32
5.1 Advalight Company Overview 32
5.1.1 Advalight Pipeline Products and Ongoing Clinical Trials Overview 32
5.2 Aesthetic Medical Device Company Overview 33
5.2.1 Aesthetic Medical Device Pipeline Products and Ongoing Clinical Trials Overview 33
5.3 Aesthetics Point Ltd. Company Overview 35
5.3.1 Aesthetics Point Ltd. Pipeline Products and Ongoing Clinical Trials Overview 35
5.4 AirXpanders, Inc. Company Overview 36
5.4.1 AirXpanders, Inc. Pipeline Products and Ongoing Clinical Trials Overview 36
5.5 Allergan, Inc. Company Overview 40
5.5.1 Allergan, Inc. Pipeline Products and Ongoing Clinical Trials Overview 40
5.6 Ambicare Health Ltd Company Overview 49
5.6.1 Ambicare Health Ltd Pipeline Products and Ongoing Clinical Trials Overview 49
5.7 Andrew Technology, LLC Company Overview 52
5.7.1 Andrew Technology, LLC Pipeline Products and Ongoing Clinical Trials Overview 52
5.8 Anika Therapeutics, Inc. Company Overview 53
5.8.1 Anika Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 53
5.9 Avita Medical Ltd Company Overview 55
5.9.1 Avita Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview 55
5.10 BioPhotas, Inc. Company Overview 60
5.10.1 BioPhotas, Inc. Pipeline Products and Ongoing Clinical Trials Overview 60
5.11 BioPolymer GmbH and Co. KG Company Overview 62
5.11.1 BioPolymer GmbH and Co. KG Pipeline Products and Ongoing Clinical Trials Overview 62
5.12 Biosculpture Technology, Inc. Company Overview 66
5.12.1 Biosculpture Technology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 66
5.13 Body Organ Biomedical Corp. Company Overview 68
5.13.1 Body Organ Biomedical Corp. Pipeline Products and Ongoing Clinical Trials Overview 68
5.14 Chromogenex Technologies Limited Company Overview 70
5.14.1 Chromogenex Technologies Limited Pipeline Products and Ongoing Clinical Trials Overview 70
5.15 Cozart plc Company Overview 71
5.15.1 Cozart plc Pipeline Products and Ongoing Clinical Trials Overview 71
5.16 Cynosure, Inc. Company Overview 72
5.16.1 Cynosure, Inc. Pipeline Products and Ongoing Clinical Trials Overview 72
5.17 Cytophil, Inc. Company Overview 80
5.17.1 Cytophil, Inc. Pipeline Products and Ongoing Clinical Trials Overview 80
5.18 Cytori Therapeutics, Inc. Company Overview 81
5.18.1 Cytori Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 81
5.19 Cytosial Biomedic, S.a.s. Company Overview 84
5.19.1 Cytosial Biomedic, S.a.s. Pipeline Products and Ongoing Clinical Trials Overview 84
5.20 Dermele Skin Care, LLC Company Overview 86
5.20.1 Dermele Skin Care, LLC Pipeline Products and Ongoing Clinical Trials Overview 86
5.21 Ellman International, Inc. Company Overview 87
5.21.1 Ellman International, Inc. Pipeline Products and Ongoing Clinical Trials Overview 87
5.22 Erchonia Corporation Company Overview 88
5.22.1 Erchonia Corporation Pipeline Products and Ongoing Clinical Trials Overview 88
5.23 Eternity Healthcare Inc. Company Overview 90
5.23.1 Eternity Healthcare Inc. Pipeline Products and Ongoing Clinical Trials Overview 90
5.24 EternoGen, LLC Company Overview 91
5.24.1 EternoGen, LLC Pipeline Products and Ongoing Clinical Trials Overview 91
5.25 Eve Aesthetics Ltd. Company Overview 92
5.25.1 Eve Aesthetics Ltd. Pipeline Products and Ongoing Clinical Trials Overview 92
5.26 FibroGen, Inc. Company Overview 93
5.26.1 FibroGen, Inc. Pipeline Products and Ongoing Clinical Trials Overview 93
5.27 Forticell Bioscience, Inc. Company Overview 95
5.27.1 Forticell Bioscience, Inc. Pipeline Products and Ongoing Clinical Trials Overview 95
5.28 Genethia Phrima SRL Company Overview 96
5.28.1 Genethia Phrima SRL Pipeline Products and Ongoing Clinical Trials Overview 96
5.29 Genzyme Corporation Company Overview 97
5.29.1 Genzyme Corporation Pipeline Products and Ongoing Clinical Trials Overview 97
5.30 Ilooda Co., Ltd. Company Overview 98
5.30.1 Ilooda Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 98
5.31 ImpLite Ltd. Company Overview 99
5.31.1 ImpLite Ltd. Pipeline Products and Ongoing Clinical Trials Overview 99
5.32 Innovia LLC Company Overview 100
5.32.1 Innovia LLC Pipeline Products and Ongoing Clinical Trials Overview 100
5.33 Invasix Company Overview 102
5.33.1 Invasix Pipeline Products and Ongoing Clinical Trials Overview 102
5.34 Juvenis Ltd. Company Overview 106
5.34.1 Juvenis Ltd. Pipeline Products and Ongoing Clinical Trials Overview 106
5.35 Keraderm LLC Company Overview 107
5.35.1 Keraderm LLC Pipeline Products and Ongoing Clinical Trials Overview 107
5.36 Khorionyx Company Overview 109
5.36.1 Khorionyx Pipeline Products and Ongoing Clinical Trials Overview 109
5.37 LandC Bio Company Overview 110
5.37.1 LandC Bio Pipeline Products and Ongoing Clinical Trials Overview 110
5.38 Medifirst Solutions, Inc. Company Overview 111
5.38.1 Medifirst Solutions, Inc. Pipeline Products and Ongoing Clinical Trials Overview 111
5.39 Medixsysteme Company Overview 113
5.39.1 Medixsysteme Pipeline Products and Ongoing Clinical Trials Overview 113
5.40 Mentor Worldwide LLC Company Overview 117
5.40.1 Mentor Worldwide LLC Pipeline Products and Ongoing Clinical Trials Overview 117
5.41 Merz Pharma GmbH and Co. KgaA Company Overview 119
5.41.1 Merz Pharma GmbH and Co. KgaA Pipeline Products and Ongoing Clinical Trials Overview 119
5.42 Moma Therapeutics, Inc. Company Overview 121
5.42.1 Moma Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 121
5.43 Mosaic Medical Technologies, Inc Company Overview 122
5.43.1 Mosaic Medical Technologies, Inc Pipeline Products and Ongoing Clinical Trials Overview 122
5.44 Neosthetic, LLC Company Overview 123
5.44.1 Neosthetic, LLC Pipeline Products and Ongoing Clinical Trials Overview 123
5.45 NivaSonix, LLC Company Overview 124
5.45.1 NivaSonix, LLC Pipeline Products and Ongoing Clinical Trials Overview 124
5.46 Northwestern University Company Overview 125
5.46.1 Northwestern University Pipeline Products and Ongoing Clinical Trials Overview 125
5.47 Northwood Medical Innovation Limited Company Overview 126
5.47.1 Northwood Medical Innovation Limited Pipeline Products and Ongoing Clinical Trials Overview 126
5.48 Nu Skin International Inc. Company Overview 127
5.48.1 Nu Skin International Inc. Pipeline Products and Ongoing Clinical Trials Overview 127
5.49 Oligo Medic, Inc. Company Overview 129
5.49.1 Oligo Medic, Inc. Pipeline Products and Ongoing Clinical Trials Overview 129
5.50 ORGEV Laboratories Company Overview 130
5.50.1 ORGEV Laboratories Pipeline Products and Ongoing Clinical Trials Overview 130
5.51 Osyris Medical Company Overview 144
5.51.1 Osyris Medical Pipeline Products and Ongoing Clinical Trials Overview 144
5.52 Philips Healthcare Company Overview 145
5.52.1 Philips Healthcare Pipeline Products and Ongoing Clinical Trials Overview 145
5.53 PhotoDerma SA Company Overview 147
5.53.1 PhotoDerma SA Pipeline Products and Ongoing Clinical Trials Overview 147
5.54 PhotoMedex, Inc. Company Overview 149
5.54.1 PhotoMedex, Inc. Pipeline Products and Ongoing Clinical Trials Overview 149
5.55 Pinnacle Therapeutics Company Overview 152
5.55.1 Pinnacle Therapeutics Pipeline Products and Ongoing Clinical Trials Overview 152
5.56 PolyNovo Biomaterials Pty Ltd Company Overview 153
5.56.1 PolyNovo Biomaterials Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 153
5.57 PS Advanced Engineering Company Overview 155
5.57.1 PS Advanced Engineering Pipeline Products and Ongoing Clinical Trials Overview 155
5.58 Rocky Mountain Biosystems Inc Company Overview 159
5.58.1 Rocky Mountain Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview 159
5.59 SANUWAVE Health, Inc. Company Overview 160
5.59.1 SANUWAVE Health, Inc. Pipeline Products and Ongoing Clinical Trials Overview 160
5.60 Sebacia Inc. Company Overview 163
5.60.1 Sebacia Inc. Pipeline Products and Ongoing Clinical Trials Overview 163
5.61 Sekisui Medical Co., Ltd. Company Overview 166
5.61.1 Sekisui Medical Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 166
5.62 SharpLight Company Overview 167
5.62.1 SharpLight Pipeline Products and Ongoing Clinical Trials Overview 167
5.63 Shin Poong Pharm.Co., Ltd. Company Overview 170
5.63.1 Shin Poong Pharm.Co., Ltd. Pipeline Products and Ongoing Clinical Trials Overview 170
5.64 Sinclair IS Pharma Plc Company Overview 171
5.64.1 Sinclair IS Pharma Plc Pipeline Products and Ongoing Clinical Trials Overview 171
5.65 Slender Medical Ltd. Company Overview 183
5.65.1 Slender Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 183
5.66 Suneva Medical, Inc. Company Overview 184
5.66.1 Suneva Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 184
5.67 Sybaritic, Inc. Company Overview 188
5.67.1 Sybaritic, Inc. Pipeline Products and Ongoing Clinical Trials Overview 188
5.68 Syneron Medical Ltd. Company Overview 191
5.68.1 Syneron Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 191
5.69 TEI Biosciences, Inc. Company Overview 196
5.69.1 TEI Biosciences, Inc. Pipeline Products and Ongoing Clinical Trials Overview 196
5.70 ThermiAesthetics Company Overview 197
5.70.1 ThermiAesthetics Pipeline Products and Ongoing Clinical Trials Overview 197
5.71 University of California, Irvine Company Overview 199
5.71.1 University of California, Irvine Pipeline Products and Ongoing Clinical Trials Overview 199
5.72 Valeant Pharmaceuticals Ltd Company Overview 200
5.72.1 Valeant Pharmaceuticals Ltd Pipeline Products and Ongoing Clinical Trials Overview 200
5.73 Yolo Medical Inc. Company Overview 201
5.73.1 Yolo Medical Inc. Pipeline Products and Ongoing Clinical Trials Overview 201
6 Aesthetic Devices- Recent Developments 203
7 Appendix 310
7.1 Methodology 310
7.2 About GlobalData 312
7.3 Contact Us 313
7.4 Disclaimer 313

1.1 List of Tables
Table 1: Aesthetic Devices - Pipeline Products by Stage of Development 17
Table 2: Aesthetic Devices - Pipeline Products by Segment 18
Table 3: Aesthetic Devices - Pipeline Products by Territory 20
Table 4: Aesthetic Devices - Pipeline Products by Regulatory Path 21
Table 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date 22
Table 6: Aesthetic Devices - Ongoing Clinical Trials 23
Table 7: Aesthetic Devices Companies - Pipeline Products by Stage of Development 24
Table 8: Aesthetic Devices - Pipeline Products by Stage of Development 27
Table 9: Advalight Pipeline Products and Ongoing Clinical Trials Overview 32
Table 10: Yellow Solid State Laser - Skin Rejuvenation - Product Status 32
Table 11: Yellow Solid State Laser - Skin Rejuvenation - Product Description 32
Table 12: Aesthetic Medical Device Pipeline Products and Ongoing Clinical Trials Overview 33
Table 13: Alluris - Product Status 33
Table 14: Alluris - Product Description 33
Table 15: Skinlumina - Product Status 34
Table 16: Skinlumina - Product Description 34
Table 17: Aesthetics Point Ltd. Pipeline Products and Ongoing Clinical Trials Overview 35
Table 18: Juvence Implant - Product Status 35
Table 19: Juvence Implant - Product Description 35
Table 20: AirXpanders, Inc. Pipeline Products and Ongoing Clinical Trials Overview 36
Table 21: AeroForm Patient Controlled Tissue Expander System - Product Status 37
Table 22: AeroForm Patient Controlled Tissue Expander System - Product Description 37
Table 23: AirXpanders, Inc. - Ongoing Clinical Trials Overview 38
Table 24: AeroForm Patient Controlled Tissue Expander System - AeroForm Patient Controlled Tissue Expansion for Breast Reconstruction 39
Table 25: AeroForm Patient Controlled Tissue Expander System - AirXpanders AeroForm Tissue Expander System for Breast Reconstruction (XPAND II) 39
Table 26: Allergan, Inc. Pipeline Products and Ongoing Clinical Trials Overview 40
Table 27: Eplica Silk - Product Status 41
Table 28: Eplica Silk - Product Description 41
Table 29: JUVEDERM Volbella - Product Status 42
Table 30: JUVEDERM Volbella - Product Description 42
Table 31: JUVEDERM VOLIFT - Product Status 43
Table 32: JUVEDERM VOLIFT - Product Description 43
Table 33: Juvederm VOLUMA XC - Product Status 44
Table 34: Juvederm VOLUMA XC - Product Description 44
Table 35: SeriGel - Product Status 45
Table 36: SeriGel - Product Description 45
Table 37: Allergan, Inc. - Ongoing Clinical Trials Overview 46
Table 38: Juvederm VOLUMA XC - Juvederm Voluma XC for the Treatment of Hypoplastic Chin 47
Table 39: Juvederm VOLUMA XC - Open Label, Single-center Study, Evaluating the Efficacy and Safety of JUVEDERM VOLUMA XC for the Facial Temporal Regions 47
Table 40: Juvederm VOLUMA XC - Voluma Treatment of HIV Facial Lipoatrophy 47
Table 41: JUVEDERM VOLIFT - A Safety and Efficacy Study of JUVEDERM VOLIFT with Lidocaine and Restylane for Nasolabial Folds in Chinese Adults 48
Table 42: Ambicare Health Ltd Pipeline Products and Ongoing Clinical Trials Overview 49
Table 43: Ambulight Rejuvenate - Product Status 49
Table 44: Ambulight Rejuvenate - Product Description 49
Table 45: Lustre Pro - Product Status 50
Table 46: Lustre Pro - Product Description 50
Table 47: Lustre Pure Light Classic - Product Status 51
Table 48: Lustre Pure Light Classic - Product Description 51
Table 49: Andrew Technology, LLC Pipeline Products and Ongoing Clinical Trials Overview 52
Table 50: HydraSolve Lipoplasty System - Visceral Fat - Product Status 52
Table 51: HydraSolve Lipoplasty System - Visceral Fat - Product Description 52
Table 52: Anika Therapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 53
Table 53: Next Generation ELEVESS Dermal Filler - Product Status 54
Table 54: Next Generation ELEVESS Dermal Filler - Product Description 54
Table 55: Avita Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview 55
Table 56: ReCell Spray-On Skin - Burns - Product Status 56
Table 57: ReCell Spray-On Skin - Burns - Product Description 56
Table 58: ReNovaCell - Aesthetics And Repigmentation - Product Status 57
Table 59: ReNovaCell - Aesthetics And Repigmentation - Product Description 57
Table 60: Avita Medical Ltd - Ongoing Clinical Trials Overview 58
Table 61: ReCell Spray-On Skin - Burns - A Multicenter Comparative Study of the ReCell Device and Autologous Split-thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries 59
Table 62: ReCell Spray-On Skin - Burns - Compassionate Use Investigational Device Exemption (IDE) Program for ReCell 59
Table 63: BioPhotas, Inc. Pipeline Products and Ongoing Clinical Trials Overview 60
Table 64: Celluma - Periorbital Wrinkles And Rhytides - Product Status 60
Table 65: Celluma - Periorbital Wrinkles And Rhytides - Product Description 60
Table 66: Celluma - Skin Rejuvenation And Sun Spots - Product Status 61
Table 67: Celluma - Skin Rejuvenation And Sun Spots - Product Description 61
Table 68: BioPolymer GmbH and Co. KG Pipeline Products and Ongoing Clinical Trials Overview 62
Table 69: Matridex - Product Status 63
Table 70: Matridex - Product Description 63
Table 71: Matridur - Product Status 64
Table 72: Matridur - Product Description 64
Table 73: Matrigel - Product Status 65
Table 74: Matrigel - Product Description 65
Table 75: Biosculpture Technology, Inc. Pipeline Products and Ongoing Clinical Trials Overview 66
Table 76: Airbrush Liposculptor IIE - Product Status 66
Table 77: Airbrush Liposculptor IIE - Product Description 66
Table 78: Airbrush Liposculptor IIIE - Product Status 67

1.2 List of Figures
Figure 1: Aesthetic Devices - Pipeline Products by Stage of Development 17
Figure 2: Aesthetic Devices - Pipeline Products by Segment 18
Figure 3: Aesthetic Devices - Pipeline Products by Territory 19
Figure 4: Aesthetic Devices - Pipeline Products by Regulatory Path 21
Figure 5: Aesthetic Devices - Pipeline Products by Estimated Approval Date 22
Figure 6: Aesthetic Devices - Ongoing Clinical Trials 23

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.